Richard Enelow, MD
Pulmonary Disease · Lebanon, NHNPI 1568429561
Payments from drug & device makers
What this record shows
That places this record below the midpoint for pulmonary disease clinicians in NH, where the typical reported total is $278.
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
Across 75 payments — averaging $4834.41 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boehringer Ingelheim$256K
- Biogen$33K
- Amgen$32K
- Novartis$32K
- Boehringer Ingelheim International GmbH$10K
- Boehringer Ingelheim Pharma GmbH & Co.kg$87
How this compares
$0 in reported general payments places this provider in the 15th percentile of 78 pulmonary disease providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrikaftaElexacaftor/Tezacaftor/Ivacaft | 42 | $926,278 |
| OfevNintedanib Esylate | 47 | $632,808 |
| CreonLipase/Protease/Amylase | 16 | $153,193 |
| Dupixent PenDupilumab | 21 | $79,221 |
| Advair HfaFluticasone Propion/Salmeterol | 93 | $62,192 |
| TezspireTezepelumab-Ekko | 12 | $51,892 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 40 | $33,070 |
| Spiriva RespimatTiotropium Bromide | 33 | $23,351 |
| SymbicortBudesonide/Formoterol Fumarate | 60 | $21,685 |
| EliquisApixaban | 21 | $15,768 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 23 | $15,565 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 23 | $14,612 |
| DuleraMometasone/Formoterol | 26 | $13,048 |
| Fluticasone Propionate HfaFluticasone Propionate | 26 | $12,346 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $11,929 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Lebanon
- Donald MahlerLebanon$411K
- Jeffrey StewartLebanon$30K
- Erik SwensonLebanon$29K
- Elliot BackerLebanon$24K
- H ParkerLebanon$13K
- Alex GiffordLebanon$8K
- Peter DelongLebanon$4K
- William WeissLebanon$1K
- John HoweLebanon$631
- John NuschkeLebanon$477
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.